Your trusted source for investing success

Tag: drugs

Isodiol International Inc. Upgrades to OTCQB

Isodiol International Inc. Upgrades to OTCQB

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today that Isodiol’s common shares have been approved for trading on the OTCQB Venture Market in the United States. The trading symbol will remain as

Canadian Marijuana Stocks

Canadian Marijuana Stocks

The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.

Isodiol International Announces U.S. Sales Launch of Hops-derived CBD Product, ImmunAG™

Isodiol International Announces U.S. Sales Launch of Hops-derived CBD Product, ImmunAG™

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today the U.S. sales launch of ImmunAG™, the market’s first non-cannabis cannabidiol (CBD) product derived from the hops plant. The time-released tablet will be unveiled at the Marijuana Business

Isodiol International Inc. Signs Letter of Intent to Acquire Bradley’s Bioscience Inc., Expands Into Vaping and THC Additive Industries

Isodiol International Inc. Signs Letter of Intent to Acquire Bradley’s Bioscience Inc., Expands Into Vaping and THC Additive Industries

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce the Company’s entrance into the vaping industry by signing a Letter of Intent (“LOI”) to acquire Bradley’s Bioscience Inc., a leading manufacturer

Lexaria Bioscience Files Innovative New Patent Application

Lexaria Bioscience Files Innovative New Patent Application

Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, announces it has filed a new patent application with the US Patent and Trademark Office (“USPTO”) utilizing the Lexaria DehydraTECHTM technology for delivery of phosphodiesterase type 5 (PDE5) inhibitors – trade names of existing well-known products

Is Trump Good for the Gold Price?

Find out about:

  • Expert opinions from gold mining experts
  • Political landscape for miners
  • Trump's impact on price
Give me my free report!  
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
3 Top Biotech Stocks that Pay Dividends

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/3-biotech-stocks-that-pay-dividends/